Report overview
Transdermal/transmucosal drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. Transdermal/transmucosal drug delivery continues to play an important role in the development of a variety of therapeutic areas in both brand and generic products.?
This report contains market size and forecasts of Transdermal/Transmucosal Drug Delivery System in global, including the following market information:
Global Transdermal/Transmucosal Drug Delivery System Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Transdermal/Transmucosal Drug Delivery System Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Transdermal/Transmucosal Drug Delivery System companies in 2021 (%)
The global Transdermal/Transmucosal Drug Delivery System market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Transdermal Drug Delivery System Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Transdermal/Transmucosal Drug Delivery System include 3M, Antares Pharma, Aveva Drug Delivery Systems, Corium International, DURECT, Pantec Biosolutions, Tapemark, Tesa Labtec and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Transdermal/Transmucosal Drug Delivery System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transdermal/Transmucosal Drug Delivery System Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transdermal/Transmucosal Drug Delivery System Market Segment Percentages, by Type, 2021 (%)
Transdermal Drug Delivery System
Transmucosal Drug Delivery System
Global Transdermal/Transmucosal Drug Delivery System Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transdermal/Transmucosal Drug Delivery System Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Transdermal/Transmucosal Drug Delivery System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transdermal/Transmucosal Drug Delivery System Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal/Transmucosal Drug Delivery System revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Transdermal/Transmucosal Drug Delivery System revenues share in global market, 2021 (%)
Key companies Transdermal/Transmucosal Drug Delivery System sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Transdermal/Transmucosal Drug Delivery System sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
Mylan
Teva
Zosano Pharma
